BACKGROUND: For reasons not fully understood, Black adults experience more socioeconomic disadvantages (SED) than their White counterparts, as well as earlier onset and greater mortality from heart ...
The Red Storm (28-6; 18-2 in Big East play) are part of the loaded East Region, which includes the top overall seed in Duke.
Many Nigerian students planning to study in the UK are discovering that a traditional Master’s degree may not be the smartest route.
A new study in the journal Nature Cities shows that as temperatures rise aboveground, the number of subway riders reporting ...
There's new evidence that GLP-1 drugs like Ozempic can reduce the risk of addiction. A study of more than 600,000 veterans followed for up to three years found that those who started taking a GLP-1 ...
The miracle of rapid weight loss has always come with fine print. Until recently, it read mostly like a list of digestive complaints — stomachaches, constipation — generally unpleasant but tolerable ...
Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. New research suggests prolonged GLP-1 use may be linked ...
WASHINGTON — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval for new drugs, the latest change from Trump administration officials ...
SAN FRANCISCO, Feb 11 (Reuters) - Among early users of Novo Nordisk's (NOVOb.CO), opens new tab new Wegovy weight-loss pill, 36% had no prior experience taking a GLP-1 medication, a new nationwide ...
The Southern California preacher wanted to illuminate Scripture with Scripture and separate real Christians from false. Expository preacher John F. MacArthur Jr., who taught Scripture to millions ...
Apple's new AirTag introduces a series of small improvements, so how does it compare to the original model from 2021? The second-generation ‌AirTag‌ arrives five years after the original, bringing ...
The impact of GLP-1 medications on weight loss is undeniable, but emerging research suggests the results may only be temporary. A growing body of evidence shows that when patients stop taking GLP-1 ...